Clinical Data Management White Paper & Articles

  1. The Hidden Truths About Prepaid Cards In Clinical Trials 3/24/2025

    Prepaid debit cards have revolutionized participant payments in clinical trials. However, questions are being raised about transparency and who sets fees.

  2. How Healthy Is Your TMF? A Check-In Before An Inspection 3/18/2025

    Explore how proper oversight of the Trial Master File (TMF) prevents inspection findings. Regular reviews, heatmaps, and risk-based assessments help ensure TMF health, and readiness for regulatory inspections.

  3. Five Key Trends In CMC 3/18/2025

    CMC is evolving with digitalization, sustainability, supply chain resilience, post-merger integration, and personalized medicine.

  4. How Smarter Financial Strategies Improve Trial Performance 3/10/2025

    CROs play a critical role in ensuring the financial and operational success of clinical trials, yet outdated budgets and inefficient payment processes continue to create challenges for sites.

  5. The Evolution Of Technology For Safety Notifications 3/6/2025

    Discover how a digital-first approach empowers sponsors to optimize safety management and drive operational efficiency in an increasingly complex, global clinical landscape.

  6. The Promise Of IQVIA One Home For Sites: A Site CEO's Perspective 2/28/2025

    By providing research sites with a unified, streamlined interface, we can reduce operational friction, enhance collaboration, and ultimately accelerate the development of new therapies.

  7. The Power Of Patient Preferences: Technology And Payment Automation 2/14/2025

    How can you leverage customizable, simplified payment methods and third-party providers to improve patient convenience in your clinical trial?

  8. Stop Paying Participants The Wrong Way 2/6/2025

    It’s time for the industry to push for payment solutions that are free from participant fees, meet participants where they are, and are fair and transparent.

  9. Navigating The Complexities Of Publication Planning 2/6/2025

    In the dynamic landscape of the life sciences industry, Medical Affairs (MA) teams and accessible digital platforms are pivotal in navigating the complexities of medical publication planning.

  10. The FDA's Remote Regulatory Assessments: The Future Of Inspections 1/31/2025

    Remote Regulatory Assessments (RRAs) provide distinct advantages over traditional inspections, such as increased efficiency, reduced travel costs, and enhanced global oversight capabilities.